Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 17-AAG | 0.001 | uM | 9 | 1250.00 | 684.27 | 1944.00 | 1739.25 | 1.1177 | 1.1724 |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 1250.00 | 684.27 | 1839.00 | 1739.25 | 1.0574 | 1.0846 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 1250.00 | 684.27 | 1658.00 | 1739.25 | 0.9533 | 0.9302 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 1250.00 | 684.27 | 1157.00 | 1739.25 | 0.6652 | 0.4774 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 1250.00 | 684.27 | 2090.00 | 1739.25 | 1.2017 | 1.2925 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 1250.00 | 684.27 | 2082.00 | 1739.25 | 1.1971 | 1.2860 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 2129.00 | 1739.25 | 1.2241 | 1.3242 | |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 1250.00 | 684.27 | 577.00 | 1739.25 | 0.3318 | -0.1190 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 1250.00 | 684.27 | 2017.00 | 1739.25 | 1.1597 | 1.2328 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 1250.00 | 684.27 | 2277.00 | 1739.25 | 1.3092 | 1.4432 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 1250.00 | 684.27 | 1821.00 | 1739.25 | 1.0470 | 1.0694 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 1250.00 | 684.27 | 1859.00 | 1739.25 | 1.0689 | 1.1014 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 1250.00 | 684.27 | 1932.00 | 1739.25 | 1.1108 | 1.1625 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 1250.00 | 684.27 | 1955.00 | 1739.25 | 1.1240 | 1.1815 |
| BT-20 | Erlotinib | 1 | uM | 9 | 1250.00 | 684.27 | 1701.00 | 1739.25 | 0.9780 | 0.9672 |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 1250.00 | 684.27 | 1982.00 | 1739.25 | 1.1396 | 1.2039 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 1250.00 | 684.27 | 1496.00 | 1739.25 | 0.8601 | 0.7882 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 1250.00 | 684.27 | 479.00 | 1739.25 | 0.2754 | -0.2328 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1543.00 | 1739.25 | 0.8872 | 0.8298 | |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1817.00 | 1739.25 | 1.0447 | 1.0661 | |
| BT-20 | Linsitinib | 1 | uM | 9 | 1250.00 | 684.27 | 1819.00 | 1739.25 | 1.0459 | 1.0677 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 1250.00 | 684.27 | 1596.00 | 1739.25 | 0.9176 | 0.8763 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 2048.00 | 1739.25 | 1.1775 | 1.2582 | |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 1250.00 | 684.27 | 1047.00 | 1739.25 | 0.6020 | 0.3717 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 1250.00 | 684.27 | 2154.00 | 1739.25 | 1.2385 | 1.3445 |